Synapse - Dmitriy Zamarin

Results (70)

CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics

Meeting Abstract

Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine

Meeting Abstract

Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Genomic analysis of high-grade serous ovarian cancer in young and older women

Meeting Abstract

Filippova, O. T.; Selenica, P.; Lee, S. S.; Pei, X.; Riaz, N.; Reis-Filho, J.; Zamarin, D.; Weigelt, B.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Compositional and architectural characterization of high-grade serous ovarian carcinomas using single cell technologies and multiplex microscopy

Meeting Abstract

Kim, S. H.; Holland, A.; Jimenez-Sanchez, A.; Bykov, Y.; Fromme, R. M.; Stylianou, A.; Walther, T.; Liu, C.; Leitao, M. M. Jr; Zivanovic, O.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer

Meeting Abstract

Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes

Meeting Abstract

Sassine, D.; Straubhar, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Kyi, C.; Leitao, M. M.; Mueller, J. J.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics

Journal Article

Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
European Urology (2020)

Fulltext@MSK | Save

BRCA mutations, homologous DNA repair deficiency, tumor mutational burden, and response to immune checkpoint inhibition in recurrent ovarian cancer

Journal Article

Liu, Y. L.; Selenica, P.; Zhou, Q.; Iasonos, A.; Callahan, M.; Feit, N. Z.; Boland, J.; Vazquez-Garcia, I.; Mandelker, D.; Zehir, A.; more...
JCO Precision Oncology (2020)

Fulltext@MSK | Save

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Journal Article

Campesato, L. F.; Budhu, S.; Tchaicha, J.; Weng, C. H.; Gigoux, M.; Cohen, I. J.; Redmond, D.; Mangarin, L.; Pourpe, S.; Liu, C.; more...
Nature Communications (2020)

Fulltext@MSK | Save

Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Journal Article

Jiménez-Sánchez, A.; Cybulska, P.; LaVigne Mager, K.; Koplev, S.; Cast, O.; Couturier, D. L.; Memon, D.; Selenica, P.; Nikolovski, I.; Mazaheri, Y.; more...
Nature Genetics (2020)

Fulltext@MSK | Save